Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Wolfe Research

BioMarin Pharmaceutical Inc.
Start price
€60.78
15.11.24 / 50%
Target price
€89.95
15.11.25
Performance (%)
-22.26%
End price
€47.25
16.11.25
Summary
This prediction ended on 16.11.25 with a price of €47.25. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -22.26%. Wolfe_Research has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioMarin Pharmaceutical Inc. -0.838% -0.838% -23.131%
iShares Core DAX® 0.048% 1.311% 11.378%
iShares Nasdaq 100 1.601% -0.902% 7.287%
iShares Nikkei 225® 3.057% 12.947% 33.767%
iShares S&P 500 0.820% 0.703% 4.930%

Comments by Wolfe_Research for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -22.26%
Target price 89.946
Change
Ends at 15.11.25

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $95.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Wolfe Research 
0
Report Share
15.11.24
In the thread Trading BioMarin Pharmaceutical Inc.
Prediction Buy
Perf. (%) -22.26%
Target price 89.946
Change
Ends at 15.11.25

Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten

Wolfe Research 
0
Report Share
16.11.25

Current prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€49.93
15.07.25
€81.42
15.07.26
4.23%
25.02.26

Wolfe Research 
15.07.25 50%